Unitree is opening IPO subscriptions on August 106. AgiBot has initiated the process for a Hong Kong listing. Component maker PaXini has closed a RMB 1 billion funding round4. ANALYSIS Taken together, the moves signal that Chinese humanoid robotics has reached the stage where capital markets, not just venture investors, are being asked to price the sector's near-term revenue potential.
Why it matters
Unitree expects first-half 2026 revenue of about CNY 1.1 billion ($156 million), representing year-on-year growth of between 35.6 percent and 45.4 percent2,3. Those figures land just as the company prepares for its initial public offering on Shanghai's STAR Market, with preliminary inquiry set for August 5 and online and offline subscriptions opening simultaneously on August 10. Unitree plans to issue 40.45 million shares — 10 percent of post-issue capital — consisting entirely of new shares, with no sale of existing holdings. The company plans to raise about 4.2 billion yuan to expand research, development, and production. Reuters has reported that Unitree is expected to be valued at more than 50 billion yuan ($7.4 billion) following the IPO, citing valuation guidance prepared by sponsor Citic Securities.
ANALYSIS A $7.4 billion valuation against $156 million in half-year revenue prices Unitree at a steep multiple — but the listing is arriving at a moment when the company can point to unit-level traction, not just prototypes.
The big picture
Unitree is not listing alone. AgiBot, which Counterpoint Research ranked first globally by humanoid robot installations in 2025, has initiated the process for a Hong Kong listing. Meanwhile, PaXini, an embodied-AI startup focused on tactile-sensing technology, completed a RMB 1 billion strategic funding round, bringing its cumulative fundraising to RMB 3.5 billion. PaXini said its tactile-sensing chips shipped nearly 1 million units over the past year, with the new funds earmarked for R&D, capacity expansion, and overseas growth.
ANALYSIS The simultaneous capital events across a full-stack humanoid maker (Unitree), an installations leader (AgiBot), and a component supplier (PaXini) suggest the sector's supply chain is maturing in parallel — not just at the integrator level.
Unitree has become one of the world's largest humanoid robot manufacturers, ranking second globally by humanoid robot installations in 2025 behind AgiBot, according to Counterpoint Research. The company plans to expand production capacity this year and may eventually assemble robots overseas, a senior executive told Nikkei Asia7. North America is described as Unitree's biggest overseas market.
Between the lines
The commercial momentum is running into a regulatory headwind. The US Federal Communications Commission recently added new foreign-produced advanced robotic devices to its Covered List, restricting future robot models from obtaining authorization. ANALYSIS For a company whose biggest overseas market is North America, the FCC action introduces a tangible constraint on the international growth story that Unitree's IPO prospectus is built around.
Unitree's Nikkei Asia interview flagged Japan as a potential engineering hub. ◆ The mention of overseas assembly and a Japan engineering presence reads as early contingency planning — a way to maintain access to regulated markets if direct Chinese exports face further restrictions.
On the product frontier, the range of what counts as "humanoid robotics" is widening. AheadForm, founded by Columbia University doctoral researcher Yuhang Hu, has introduced the Origin F1, a reportedly $150,000 desktop ultra-bionic humanoid designed for face-to-face interaction with AI, featuring biomimetic skin and facial expression mimicry1. ◆ The Origin F1 occupies a different niche from industrial humanoids, but its existence illustrates how broadly the sector's commercial ambitions now extend — from factory floors to consumer-facing social interaction.
What's next
Unitree's preliminary inquiry is scheduled for August 5, with subscriptions opening August 10 and payments due by August 12. AgiBot's Hong Kong listing timeline remains undisclosed, though the company has initiated the process. ◆ The pricing of Unitree's IPO will serve as the first public-market benchmark for Chinese humanoid robotics — setting the valuation framework that AgiBot's Hong Kong listing, likely to follow, will be measured against. Whether the FCC's restrictions dampen investor appetite or accelerate the push toward non-US markets will be visible in the subscription results within days.